- •Ticket 1
- •3. Antihypertensive agents affecting water-salt exchange. Classification. Mechanism of action. Side effects. Contraindications. Comparative evaluation of preparations.
- •4. Antiseptics of aromatic and aliphatic series. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Ticket 2.
- •Distribution of drugs in the body. Biotransformation of drugs in the body and ways of their extraction. The concept of bioavailability.
- •2. Binding, engraving, adsorbating, irritating substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •1. Suction of medicinal substances from the place of administration. Transportation of medicinal substances through cellular membranes.
- •3. Drugs stimulating fibrinolysis. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative assessment.
- •4. Halogen-containing antiseptics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Ticket 3.
- •2.Tranquilizers. Classification. Action mechanism. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •1) Means used for diagnostic purposes
- •Indications: used in case of weakened but preserved gastric function
- •2. Antiseptics - compounds of metals. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Season 4
- •Gink derivatives
- •Indications for use:
- •I Inhibition of the activity of the thromboxane system
- •III Drugs that inhibit the binding of fibrinogen to platelet glycoprotein receptors
- •Season 5
- •Indications:
- •Season 6
- •Indications:
- •3) Preparations for topical use:
- •4) Combined preparations of sulfonamides with trimethoprim
- •Ticket 7
- •1. Development of pharmacology in Russia. Pharmokopeia, its legal significance. Prescription - Jur. Document.
- •2. Counterarkinsonian funds. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Rational combination and combined drugs for the treatment of hypertension. Explain the rationality of the application.
- •Ticket 8
- •3. Anticoagulants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 9
- •3. Drugs used to treat bronchial asthma. Classification. Mechanisms of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 10
- •1. Definition of pharmacology as a science, its tasks, place among other medical and biological sciences. Scientific substantiation of the need for animal experiments.
- •Ticket 11
- •1. Dependence of the effect on the dose (concentration) of the active substance. The breadth of the therapeutic action. The value of the choice of dosage forms and methods of drug administration.
- •2. Antipsychotics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs. The concept of neuroleptanalgesia
- •3. Cardiac glycosides. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antifungal drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •I. Means used in the treatment of diseases caused by pathogenic fungi:
- •II. Drugs used in the treatment of diseases caused by opportunistic fungi (for example, with candidiasis):
- •Ticket number 12
- •Types of action of medicinal substances
- •2. Alpha and alpha, beta adrenomimetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 13
- •1. Pharmacological work of domestic physiologists and clinicians (im Sechenov, ip Pavlov, sp Botkin, ni Pirogov)
- •3. Preparations of sex hormones and their antagonists. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •Indications for use:
- •4. Antimalarial drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •Ticket 14
- •1. Features of the action and dosage of medicinal substances for various routes of administration.
- •2. Local anesthetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for the use of local anesthetics:
- •3. Preparations of fat-soluble vitamins. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Vitamin a preparations are indicated:
- •Ticket 15
- •2. Nootropics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •3. Antihypertensive drugs of peripheral neurotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Anti-tuberculosis drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 16
- •1. Types of action of medicinal substances.
- •2. Sympatholytic remedies. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antiviral agents. Classification. Mechanism of action. The nature of the action. Spectrum of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 17.
- •1. Side and toxic effects of medicinal substances. Allergic and non-allergic side effects. Toxicity. Teratogenicity. Embryotoxicity. Carcinogenicity. Idiosyncrasy.
- •2. Analeptics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Choleretic drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Anti-spirochete drugs. Classification. Mechanism of action. Indications for use. Side effects. Comparative characteristics.
- •Ticket 18.
- •1. Pharmacological work of domestic physiologists and clinicians (im Sechenov, ip Pavlov, sp Botkin, ni Pirogov)
- •2. Beta-adrenergic agonists. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Antacids. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative characteristics.
- •Ticket 19
- •1. The combined effect of drugs. Synergy. Antagonism. Antidote.
- •2.Sleeping drugs. Classification by chemical structure. Mechanism of action. Side effects. Contraindications Comparative evaluation. Possibilities for the development of addiction.
- •3. Class II antiarrhythmic drugs (Beta-blockers). Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Complications arising from the use of antibiotics, measures for their prevention.
- •Ticket 20
- •1. Changes in the body's reactions to medicinal substances during their repeated administration. The concept of addiction, drug dependence, tachyphylaxis, sensitization. Cumulation of drugs.
- •2. Ganglion blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of the drug.
- •3. Means that reduce the secretion of gastric glands. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of drugs.
- •Ticket 21
- •1. Basic principles of first aid for acute drug poisoning.
- •2. Alpha-adrenergic blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of drugs.
- •3.Calcium channel blockers for the treatment of coronary heart disease. Classification Mechanism of action Side effects Contraindications Comparative assessment of drugs
- •Ticket number 22
- •3). Leukopoiesis stimulants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket number 23
- •2). Narcotic (opioid) analgesics. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs. Antagonists of narcotic analgesics.
- •1. Plant origin
- •2. Synthetic morphine substitutes
- •3). Gastroprotectors. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •Ticket number 24
- •III. Agents that activate the gabAergic system
- •IV. Agents that lower the activity of the glutamatergic system
- •3). Diuretics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •2). Antiepileptic drugs. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •Ticket 25
- •1. Side and toxic effects of medicinal substances. Allergic and non-allergic side effects. Toxicity. Teratogenicity. Embryotoxicity. Carcinogenicity. Idiosyncrasy.
- •3. Antitussives. Classification Mechanism of action Indications for use Side effects Contraindications Comparative assessment of drugs
- •Ticket 26
- •2. Sedatives. Classification. Mechanism of action. Indications for use Side effects Contraindications Comparative evaluation of drugs.
- •3. Anti-inflammatory drugs of steroid structure. Classification Mechanism of action Indications for use Side effects Contraindications Comparative assessment of drugs
- •Ticket 27
- •1. Basic principles and methods of testing new medicinal substances. The concepts of "placebo" and "blind" control. The ethical side of prescribing a placebo.
- •3. Means that help stop bleeding (hemostatics). Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of drugs.
- •3) Preparations for topical use:
- •4) Combined preparations of sulfonamides with trimethoprim
- •Ticket number 28
- •1. Combined action of medicinal substances. Synergy. Antagonism. Antidote.
- •2. Psychostimulants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket number 29
- •1. Dependence of the effect on the dose (concentration) of the active substance. The breadth of the therapeutic action. The value of the choice of dosage forms and methods of drug administration.
- •2. Alpha-adrenergic blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Drugs affecting immunity. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antifungal drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 30
- •2. Sympatholytic agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Preparations of pancreatic hormones. Synthetic hypoglycemic agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Anti-spirochete drugs. Classification. Mechanism of action. Indications for use. Side effects. Comparative characteristics.
- •Ticket 31
- •1. Distribution of medicinal substances in the body. Biotransformation of medicinal substances in the body and ways of their excretion. Concept and bioavailability.
- •2. Narcotic (opioid) analgesics. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs. Antagonists of narcotic analgesics.
- •3. Laxatives. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Complications arising from the use of antibiotics, measures for their prevention.
- •Ticket 32.
- •3. Stimulants of respiration. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 33.
- •1. Features of the action and dosage of medicinal substances for various routes of administration.
- •2. Antipsychotics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs. The concept of neuroleptanalgesia.
- •3. Class IV antiarrhythmics (calcium channel blockers). Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 34
- •1) Development of pharmacology in Russia. Pharmacology and its legal significance. Treating the recipe as a legal document.
- •3... Antihypertensive drugs that affect the renin-angiotensin system. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antiviral agents. Classification. Mechanism of action. The nature of the action. Indications for use. Side effects. Contraindications Comparative characteristics of drugs.
- •Ticket 35
- •6. Homeopathy, basic principles. Evaluation of the homeopathic treatment method.
- •2. Nootropics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •3) Drugs used in myocardial infarction. Classification. Mechanism of action. Side effects. Contraindications Indications for use. Comparative characteristics
- •Ticket 36
- •2. Local anesthetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for the use of local anesthetics:
- •3) Anti-atherosclerotic drugs. Classification, Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation.
- •Indications:
- •Ticket 37
- •Basic principles (mechanisms) of action of medicinal substances. Their interaction with receptors.
- •Antihypertensive drugs of central neurotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •1. Basic principles (mechanisms) of action of medicinal substances. Their interaction with receptors.
- •3. Antihypertensive drugs of central neurotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 38
- •4. Antiblastic substances. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 39
- •4. Differences between chemotherapeutic agents and antiseptics. Basic principles of ht. Criteria for evaluation.
- •Ticket 40.
- •3. Preparations of water-soluble vitamins. Classification. Mechanism of action. Indications. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antihelminthic agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 41.
- •1. Principles of drug discovery. Ways of synthesis of pharmacological substances. Obtaining preparations from plant and animal raw materials.
- •Inhalation : volatile liquids: ether, fluorothane, sevoflurane, isoflurane, methoxyflurane
- •3. Class III antiarrhythmic drugs (potassium channel blockers). Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •4. Dyes. Detergents. Oxidizing agents. Acids and alkalis.
- •Ticket 42
- •1. Pharmacological work of domestic physiologists and clinicians (im Sechenov, ip Pavlov, sp Botkin, ni Pirogov).
- •2. Beta-adrenergic agonists. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Vomiting and antiemetic. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 43
- •1. The combined action of medicinal substances. Synergy. Antagonism. Antidote.
- •2. Antiparkinsonian drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Enzyme preparations. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •Ticket 44.
- •The dependence of the effect on the dose (concentration) of the active substance. The breadth of the therapeutic action. The value of the choice of dosage forms and methods of drug administration.
- •2. Curariform funds. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Means that affect appetite. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •1.Media that stimulate appetite:
- •Ticket 45.
- •1. Types of action of medicinal substances.
- •2. Antidepressants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Gink derivatives
- •Indications for use:
- •4. Anti-tuberculosis drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 46
- •Ticket 47
- •3. Means that increase the tone and contraction of the myometrium. Classification. Mechanism of action. Indications for use. Contraindications Comparative evaluation of drugs.
- •4. Halogen-containing antiseptics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Season 48
- •Distribution of drugs in the body. Biotransformation of drugs in the body and ways of their extraction. The concept of bioavailability.
- •2). Antiepileptic drugs. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •III. Agents that activate the gabAergic system
- •IV. Agents that lower the activity of the glutamatergic system
- •3. Antiadrenergic drugs for the treatment of coronary heart disease. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antiseptics - metal compounds. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Inhalation : volatile liquids: ether, fluorothane, sevoflurane, isoflurane, methoxyflurane
- •3. Blockers of calcium channels for the treatment of hypertension. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 50
- •1. Side and toxic effects of medicinal substances. Allergic and non-allergic side effects. Toxicity. Teratogenicity. Embryotoxicity. Carcinogenicity. Idiosyncrasy.
- •2. Ganglion blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of the drug.
- •3. Preparations of pituitary hormones. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use
- •Indications for use
- •Indications for use:
- •Ticket 51
- •1. Features of the action and dosage of medicinal substances for various routes of administration.
- •2. Alpha and alpha, beta adrenomimetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Glycosidic intoxication. Preventive and emergency measures.
- •Ticket 52
- •3. Antihypertensive drugs of myotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
4. Antiblastic substances. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
Classification:
I. Alkylating agents:
a) derivatives of chloroethylamine (mustard gas) - dopane, sarcolysin;
b) derivatives of ethyleneimine - thiophosphamide, benzotef;
c) derivatives of methanesulfonic acid - mielosan.
II. Antimetabolites:
a) folic acid antagonists - methotrexate;
b) purine antagonists - mercaptopurine;
c) pyrimidine antagonists - fluorouracil.
III. Antineoplastic antibiotics - doxorubicin hydrochloride, dactinomycin.
IV. Herbal antineoplastic agents (alkaloids) - vinblastine, vincristine, colhamin.
V. Enzyme preparations with antitumor activity - L-asparaginase.
Vi. Hormonal drugs and their antagonists - phosphestrol, tamoxifen, prednisolone.
Vii. Interferons, interleukins - aldesleukin.
VIII. Preparations of various chemical groups.
a) Platinum preparations - cystplatin or platidiam, polyplatilen, platinum.
b) Urea derivatives - hydroxyurea, lomustine.
c) Triazenes — dacarbazine or DTIK.
Mechanism of action :
Alkylating: impairment of DNA replication due to cross-linking.
Antimetabolites: suppression of the synthesis of purines and NA
Antineoplastic antibiotics: suppression of nc synthesis and function
Plant-based: blocking mitosis at the metaphase stage
Hormonal drugs: suppression of NK synthesis of hormone-sensitive target cells.
Asparaginase enzymes: impaired protein synthesis due to asparagine deficiency
Indications: cisplastin - ovarian cancer, soft tissue sarcoma, breast cancer
Mercaptopurine - acute leukemia
Methotrexate - acute leukemia, breast cancer, uterine chorionepithelioma
Prospidin - laryngeal cancer
Colhamin - skin cancer
Rosevin - chorionepithelioma of the uterus, reticulosarcoma, lymphogranulomatosis
Vincristine - acute leukemia in children
Asparaginase - lymphosarcoma, acute lymphoblastic leukemia, reticulosarcoma
Adriamycin: acute leukemia, reticulosarcoma, lymphogranulomatosis
Glucocorticoids: lymphogranulomatosis, acute leukemia
Side effects: irritation of the gastrointestinal tract, cardio-, hepato-, nephrotoxic, immunosuppressive, mutagenic, teratogenic effects.
Contraindications: oppression of hematopoiesis, acute infections, liver and kidney disease.
Ticket 39
Types of action of medicinal substances.
M-anticholinergic drugs. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
Nitrates used for coronary heart disease. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
Differences between chemotherapeutic substances and antiseptics. Basic principles of HT. Criteria for evaluation.
1. Types of action of medicinal substances.
1. Local action - the action of drugs at the site of their application (before absorption into the blood, for example, astringents, local anesthetics).
2. Reflex action - the action that occurs when the drug stimulates the receptors of the afferent link of the reflex.
3. Resorptive action (general) - the action of drugs after their absorption into the blood.
4. Direct action - action directed directly at that organ or system where there are pathological changes and manifested along with the main action.
5. Indirect action (indirect) - the result of direct action, as a result of which the activity of another organ or system is improved.
6. The main (main) action is a manifestation of the pharmacological action of a medicinal substance, which is used in each case for therapeutic or prophylactic purposes.
7. Side effect - the effects of a medicinal substance in a therapeutic dose, which in a particular case are undesirable and are manifested along with the main action.
8. Teratogenic effect (from the Greek. Teras - freak) occurs from the beginning of 4 to 8-10 weeks of pregnancy and is accompanied by the development of anomalies of the internal organs and systems of the fetus, ie. various deformities.
9. Embryotoxic action (from the Greek embryon - embryo). It occurs in the first 3 weeks after fertilization and consists in the negative effect of drugs on the embryo in the lumen of the fallopian tubes or uterus.
10. Fetotoxic effect - the effect of the drug on the fetus at a later time, which does not cause deformity (from the Greek. Fetus - fruit). This is the result of the reaction of a ripening or already mature fetus to drugs, which is practically not much different from the reaction of an adult and can be the cause of severe pathology or even death of the fetus and newborn.
2. M-anticholinergic drugs. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
-Atropin-stimulates the central nervous system.
-Platifillin-dilates blood vessels.
-Pirenzepine-selectively blocks the receptors of the glands of the stomach, used for peptic ulcer disease.
-Scopolamine is rarely used, as it can cause disorientation and amnesia, depresses the central nervous system.
Mechanism of action: block M-cholinergic receptors, and prevent the interaction of acetylcholine with them. Dilatation of the pupil, increase in IOP, accommodation paralysis, tachycardia, expansion of the bronchi, decrease in peristalsis; bladder, ureters, uterus - decreased smooth muscle tone.
Indications: fundus examination, eye trauma, cholelithiasis, pancreatin, to relax the uterus, motion sickness, poisoning with M-cholinomimetics (atropine)
Side effects: increased IOP, impaired near vision, tachycardia, constipation, dysphagia.
Contraindications:
1.Glaucoma;
2. Heart rate more than 90 beats per minute;
3.Tachyarrhythmias;
4. Intestinal atony;
5.Adenoma of the prostate gland.
Poisoning of children with atropine-containing plants, measures of assistance: gastric lavage, activated charcoal, the use of anticholinesterase drugs - physostigmine, proserin.
3. Nitrates used in coronary heart disease.Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
Classification:
I. NITROGLYCERIN PREPARATIONS:
A. Short-acting:
(The effect develops in 1-3 minutes, lasts 20-30 minutes, is used to stop an attack of angina pectoris.)
-Nitroglycerin - tablets, capsules, alcohol solution.
-Nitromint - aerosol
B. Average duration:
(the effect develops in 30-40 minutes, lasts 4-6 hours)
1. Tablets: sustac. (effect duration 7-8 hours)
2. Capsules: nitromac.
B. Long-acting:
(the effect develops in 1-2 hours, lasts 12-24 hours)
Plasters and transdermal discs: nitroderm.
The formation of addiction and a decrease in efficiency is possible.
II. DINITRATE ISOSORBIDE PREPARATIONS:
A. Average duration:
(the effect develops in 20-30 minutes, lasts 4-6 hours)
1. Tablets: nitrosorbide.
2. Capsules: isosorb.
B. Moderately prolonged:
(the effect develops in 30-40 minutes, lasts 6-8 hours)
1. Tablets: cardiket-retard.
III. ISOSORBIDE MONONITRATE PREPARATIONS:
(the effect develops in 20-30 minutes, lasts 10-12 hours)
Tablets: olicard.
Mechanism of action: expand peripheral veins and arteries - decrease in venous return to the heart and systemic vascular resistance, decrease in pre- and afterload on the heart, decrease in heart function. Expand large coronary vessels, suppression of the central links of coronary reflexes - increased delivery of blood and oxygen to the heart. All of these effects reduce the heart's need for oxygen.
SIDE EFFECTS :
1. Headaches.
2. Hypotension.
3. Reflex tachycardia (combination with alpha, beta-blockers or beta-blockers).
4. Increased intraocular pressure.
CONTRAINDICATIONS:
1. HELL is less than 100/60.
2. Tachycardia.
3. Increased intracranial pressure.
4. Glaucoma (especially open-angle).
